投资银行Leerink Partners近日宣布,开始对BridgeBio Oncology Therapeutics, Inc进行研究覆盖,并给予该股"跑赢大盘"评级,目标价格设定为25美元。
投资银行Leerink Partners近日宣布,开始对BridgeBio Oncology Therapeutics, Inc进行研究覆盖,并给予该股"跑赢大盘"评级,目标价格设定为25美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.